Dacomitinib
Overview
Dacomitinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2105719).
API suppliers (2)
Suppliers of Dacomitinib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
1 of 2 holds a GMP certificate on record in the EU or UK registers
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- CHONGQING CARELIFE PHARMACEUTICAL CO LTDChina1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (3 approved US products), the latest listed US patent on Dacomitinib expires 27 Sept 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide;hydrate
- Canonical SMILES
- COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4.O
- InChIKey
- BSPLGGCPNTZPIH-IPZCTEOASA-N
Do you supply Dacomitinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.